SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variants

The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) antibody neutralization response and its evasion by emerging viral variants and variant of concern (VOC) are unknown, but critical to understand reinfection risk and breakthrough infection following vaccination. Antibody immunoreactivi...

Descripción completa

Detalles Bibliográficos
Autores principales: Tea, Fiona, Ospina Stella, Alberto, Aggarwal, Anupriya, Ross Darley, David, Pilli, Deepti, Vitale, Daniele, Merheb, Vera, Lee, Fiona X. Z., Cunningham, Philip, Walker, Gregory J., Fichter, Christina, Brown, David A., Rawlinson, William D., Isaacs, Sonia R., Mathivanan, Vennila, Hoffmann, Markus, Pöhlman, Stefan, Mazigi, Ohan, Christ, Daniel, Dwyer, Dominic E., Rockett, Rebecca J., Sintchenko, Vitali, Hoad, Veronica C., Irving, David O., Dore, Gregory J., Gosbell, Iain B., Kelleher, Anthony D., Matthews, Gail V., Brilot, Fabienne, Turville, Stuart G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291755/
https://www.ncbi.nlm.nih.gov/pubmed/34228725
http://dx.doi.org/10.1371/journal.pmed.1003656

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291755/
https://www.ncbi.nlm.nih.gov/pubmed/34228725
http://dx.doi.org/10.1371/journal.pmed.1003656

Ejemplares similares